Rating History for Trevi Therapeutics (TRVI) by BMO Capital

More Stocks Rated by BMO Capital | Latest Ratings for TRVI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/7/2026 Connor Murphy Maintain Outperform
(N/A)		 36.00
(N/A)		  
 		   Details